Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports

Bibliographic Details
Main Authors: Qiang Chen, Yunxuan Zhang, Chenyu Sun, Li Liu, Xiaoyan Luo, Hua Wang, Sili Ni
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1282607/full
_version_ 1827822033164042240
author Qiang Chen
Qiang Chen
Yunxuan Zhang
Chenyu Sun
Li Liu
Xiaoyan Luo
Hua Wang
Sili Ni
author_facet Qiang Chen
Qiang Chen
Yunxuan Zhang
Chenyu Sun
Li Liu
Xiaoyan Luo
Hua Wang
Sili Ni
author_sort Qiang Chen
collection DOAJ
first_indexed 2024-03-12T01:51:22Z
format Article
id doaj.art-8840a5369fb341f09087aa7f858bca6a
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-12T01:51:22Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-8840a5369fb341f09087aa7f858bca6a2023-09-08T12:15:47ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-09-011310.3389/fonc.2023.12826071282607Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reportsQiang Chen0Qiang Chen1Yunxuan Zhang2Chenyu Sun3Li Liu4Xiaoyan Luo5Hua Wang6Sili Ni7Department of Dermatology, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing, ChinaDepartment of Pediatrics, Chongqing University Three Gorges Hospital, Chongqing, ChinaDepartment of Burn and Plastic Surgery, Children’s Hospital of Chongqing Medical University, Chongqing, ChinaAMITA Health Saint Joseph Hospital Chicago, University of Illinois at Chicago, Chicago, IL, United StatesDepartment of Dermatology, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing, ChinaDepartment of Dermatology, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing, ChinaDepartment of Dermatology, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing, ChinaDepartment of Dermatology, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing, Chinahttps://www.frontiersin.org/articles/10.3389/fonc.2023.1282607/fullinfantile hemangiomarecurrencepropranololβ2-adrenergic receptorsalbutamolprocaterol
spellingShingle Qiang Chen
Qiang Chen
Yunxuan Zhang
Chenyu Sun
Li Liu
Xiaoyan Luo
Hua Wang
Sili Ni
Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports
Frontiers in Oncology
infantile hemangioma
recurrence
propranolol
β2-adrenergic receptor
salbutamol
procaterol
title Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports
title_full Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports
title_fullStr Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports
title_full_unstemmed Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports
title_short Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports
title_sort corrigendum case report deterioration of infantile hemangioma related to oral or nebulized administration of β2 ar agonist three cases reports
topic infantile hemangioma
recurrence
propranolol
β2-adrenergic receptor
salbutamol
procaterol
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1282607/full
work_keys_str_mv AT qiangchen corrigendumcasereportdeteriorationofinfantilehemangiomarelatedtooralornebulizedadministrationofb2aragonistthreecasesreports
AT qiangchen corrigendumcasereportdeteriorationofinfantilehemangiomarelatedtooralornebulizedadministrationofb2aragonistthreecasesreports
AT yunxuanzhang corrigendumcasereportdeteriorationofinfantilehemangiomarelatedtooralornebulizedadministrationofb2aragonistthreecasesreports
AT chenyusun corrigendumcasereportdeteriorationofinfantilehemangiomarelatedtooralornebulizedadministrationofb2aragonistthreecasesreports
AT liliu corrigendumcasereportdeteriorationofinfantilehemangiomarelatedtooralornebulizedadministrationofb2aragonistthreecasesreports
AT xiaoyanluo corrigendumcasereportdeteriorationofinfantilehemangiomarelatedtooralornebulizedadministrationofb2aragonistthreecasesreports
AT huawang corrigendumcasereportdeteriorationofinfantilehemangiomarelatedtooralornebulizedadministrationofb2aragonistthreecasesreports
AT silini corrigendumcasereportdeteriorationofinfantilehemangiomarelatedtooralornebulizedadministrationofb2aragonistthreecasesreports